Monique M. Gardner

Monique M. Gardner

Auto-generated profile, based on publicly available information

Monique M. Gardner

University of Pennsylvania

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2023 in Critical Care
Verified
Journal Article
Open access
PDF file
MGMonique M. Gardner
Monique M. Gardner
DHDavid A. Hehir
David A. Hehir
RRRon W. Reeder
Ron W. Reeder
TATageldin Ahmed
Tageldin Ahmed
MBMichael J. Bell
Michael J. Bell
ATAlexis A. Topjian
Alexis A. Topjian
Introduction: Though early hypotension after pediatric in-hospital cardiac arrest (IHCA) is associated with inferior outcomes, ideal post-arrest blood pressure (BP) targets have not been established. We aimed to leverage prospectively collected BP data to explore the association of post-arrest BP thresholds with outcomes. We hypothesized that post-arrest systolic and diastolic BP thresholds would be higher than the currently recommended post-cardiopulmonary resuscitation BP targets and would be associated with higher rates of survival to hospital discharge. Methods: We performed a secondary analysis of prospectively collected BP data from the first 24 h following return of circulation from index IHCA events enrolled in the ICU-RESUScitation trial (NCT02837497). The lowest documented systolic BP (SBP) and diastolic BP (DBP) were percentile-adjusted for age, height and sex. Receiver operator characteristic curves and cubic spline analyses controlling for illness category and presence of pre-arrest hypotension were generated exploring the association of lowest post-arrest SBP and DBP with survival to hospital discharge and survival to hospital discharge with favorable neurologic outcome (Pediatric Cerebral Performance Category of 1–3 or no change from baseline). Optimal cutoffs for post-arrest BP thresholds were based on analysis of receiver operator characteristic curves and spline curves. Logistic regression models accounting for illness category and pre-arrest hypotension examined the associations of these thresholds with outcomes. Results: Among 693 index events with 0–6 h post-arrest BP data, identified thresholds were: SBP > 10th percentile and DBP > 50th percentile for age, sex and height. Fifty-one percent (n = 352) of subjects had lowest SBP above threshold and 50% (n = 346) had lowest DBP above threshold. SBP and DBP above thresholds were each associated with survival to hospital discharge (SBP: aRR 1.21 [95% CI 1.10, 1.33]; DBP: aRR 1.23 [1.12, 1.34]) and survival to hospital discharge with favorable neurologic outcome (SBP: aRR 1.22 [1.10, 1.35]; DBP: aRR 1.27 [1.15, 1.40]) (all p < 0.001). Conclusions: Following pediatric IHCA, subjects had higher rates of survival to hospital discharge and survival to hospital discharge with favorable neurologic outcome when BP targets above a threshold of SBP > 10th percentile for age and DBP > 50th percentile for age during the first 6 h post-arrest.

23 June 2017 in Congenital Heart Disease
Verified
Journal Article
Closed access
PDF file
MGMonique M. Gardner
Monique M. Gardner
MCMeryl S. Cohen
Meryl S. Cohen
Noncompaction is a poorly understood form of cardiomyopathy that typically affects the left ventricle and may be associated with congenital heart disease. Right ventricular noncompaction (RVNC) may occur when the left ventricle is affected but is rarely seen in isolation. RVNC may have clinical significance affecting surgical and long-term outcomes. We describe the diagnosis and clinical course in three patients at our institution. We performed a retrospective review of patients diagnosed with RVNC over a 12-month period at our institution and reviewed their imaging and clinical course. Three patients were identified. All had diagnosis of RVNC by echocardiography (echo) made on postnatal imaging which reviewed degree of trabeculation, and noncompaction-to-compaction ratio of the myocardium. Patient A was a neonate with hypoplastic left heart syndrome (HLHS) who underwent a Norwood operation with Sano modification. Her postoperative course was notable for low-normal RV function. She returned with a pericardial effusion warranting immediate pericardiocentesis. She continued to have effusions, which were medically managed. She was subsequently found to have an RV apical pseudoaneurysm, which required surgical resection. Patient B was a neonate with HLHS who had a Norwood operation with Sano modification. She had low-normal RV function on echo. She required medical management for pericardial effusion. Patient C was a neonate with HLHS who also underwent a Norwood operation with Sano modification. His postoperative course was notable for elevated serum brain natriuretic peptide, which was treated with digoxin. RVNC is a rare diagnosis with limited known clinical impact. One of these patients had a very rare complication after pericardiocentesis (pseudoaneurysm) that may have been related to the RVNC. Our understanding of this disease process is limited and requires additional investigation, but emphasizes the importance of appropriate diagnosis to allow for timely follow-up and counseling for this unique population.

13 November 2024 in Resuscitation
Verified
Journal Article
Closed access
MGMonique M. Gardner
Monique M. Gardner
RMRyan W. Morgan
Ryan W. Morgan
RRRon Reeder
Ron Reeder
KGKimia Ghaffari
Kimia Ghaffari
LOLaura Ortmann
Laura Ortmann
TSTodd Sweberg
Todd Sweberg

19 September 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
RSRachel J. Shustak
Rachel J. Shustak
JHJing Huang
Jing Huang
VTVicky Tam
Vicky Tam
ASAlyson Stagg
Alyson Stagg
TGTherese M. Giglia
Therese M. Giglia
MGMonique M. Gardner
Monique M. Gardner
Background: Poor interstage weight gain is a risk factor for adverse outcomes in infants with hypoplastic left heart syndrome. We sought to examine the association of neighborhood social vulnerability and interstage weight gain and determine if this association is modified by enrollment in our institution's Infant Single Ventricle Management and Monitoring Program (ISVMP). Methods and Results: We performed a retrospective single‐center study of infants with hypoplastic left heart syndrome before (2007–2010) and after (2011–2020) introduction of the ISVMP. The primary outcome was interstage weight gain, and the secondary outcome was interstage growth failure. Multivariable linear and logistic regression models were used to examine the association between the Social Vulnerability Index and the outcomes. We introduced an interaction term into the models to test for effect modification by the ISVMP. We evaluated 217 ISVMP infants and 111 pre‐ISVMP historical controls. The Social Vulnerability Index was associated with interstage growth failure ( P =0.001); however, enrollment in the ISVMP strongly attenuated this association ( P =0.04). Pre‐ISVMP, as well as high‐ and middle‐vulnerability infants gained 4 g/d less and were significantly more likely to experience growth failure than low‐vulnerability infants (high versus low: adjusted odds ratio [aOR], 12.5 [95% CI, 2.5–62.2]; middle versus low: aOR, 7.8 [95% CI, 2.0–31.2]). After the introduction of the ISVMP, outcomes did not differ by Social Vulnerability Index tertile. Infants with middle and high Social Vulnerability Index scores who were enrolled in the ISVMP gained 4 g/d and 2 g/d more, respectively, than pre‐ISVMP controls. Conclusions: In infants with hypoplastic left heart syndrome, high social vulnerability is a risk factor for poor interstage weight gain. However, enrollment in the ISVMP significantly reduces growth disparities.

16 February 2023 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
AJAndrea L. Jones
Andrea L. Jones
JFJennifer Faerber
Jennifer Faerber
JHJing Huang
Jing Huang
SASteve Ampah
Steve Ampah
YWYan Wang
Yan Wang
LMLaura Mercer-Rosa
Laura Mercer-Rosa

18 April 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
RSRachel J. Shustak
Rachel J. Shustak
JFJennifer A. Faerber
Jennifer A. Faerber
ASAlyson Stagg
Alyson Stagg
DHDavid A. Hehir
David A. Hehir
SNShobha S. Natarajan
Shobha S. Natarajan
MGMonique M. Gardner
Monique M. Gardner
Background: The impact of home monitoring on unanticipated interstage readmissions in infants with hypoplastic left heart syndrome has not been previously studied. We sought to examine the association of our institution's Infant Single Ventricle Management and Monitoring Program (ISVMP) with readmission frequency, cumulative readmission days, and readmission illness severity and to identify patient‐level risk factors for readmission. Methods and Results: We performed a retrospective single‐center cohort study comparing infants with hypoplastic left heart syndrome enrolled in ISVMP (December 2010–December 2019) to historical controls (January 2007–November 2010). The primary outcome was number of readmissions per interstage days. Secondary outcomes were cumulative interstage readmission days and occurrence of severe readmissions. Inverse probability weighted and multivariable generalized linear models were used to examine the association between ISVMP and the outcomes. We compared 198 infants in the ISVMP to 128 historical controls. Infants in the ISVMP had more than double the risk of interstage readmission compared with controls (adjusted incidence rate ratio, 2.38 [95% CI, 1.50–3.78]; P =0.0003). There was no difference in cumulative interstage readmission days (adjusted incidence rate ratio, 1.02 [95% CI, 0.69–1.50]; P =0.90); however, infants in the ISVMP were less likely to have severe readmissions (adjusted odds ratio, 0.28 [95% CI, 0.11–0.68]; P =0.005). Other factors independently associated with number of readmissions included residing closer to our center, younger gestational age, genetic syndrome, and discharge on exclusive enteral feeds. Conclusions: Infants in the ISVMP had more frequent readmissions but comparable readmission days and fewer severe unanticipated readmissions. These findings suggest that home monitoring can reduce interstage morbidity without increasing readmission days.